PA
RMNI icon

PharVision Advisers’s Rimini Street RMNI Stock Holding History

PharVision Advisers’s Portfolio RMNI Stock Details RMNI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,720
Closed -$68K – 118
2026
Q1 		$68K Buy
+20,720
New +$71.9K 0.69% 77
2025
Q4 		– Sell
-48,205
Closed -$226K – 958
2025
Q3 		$226K Buy
+48,205
New +$214K 0.13% 409

Other funds holding RMNI

ASP
Adams Street Partners Chicago, Illinois $443M AUM 49.46% 1-Year Est. Return
CM
Conifer Management New York $607M AUM 29.07% 1-Year Est. Return
BCM
Brooktree Capital Management Gand Rapids, Michigan $153M AUM 14.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $551M AUM 49.99% 1-Year Est. Return
SM
Samjo Management New York $293M AUM 57.03% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

PharVision Advisers's RMNI Position: Q2 2026 in Review

PharVision Advisers sold out of Rimini Street (RMNI) in Q2 2026, closing a stake of 20,720 shares — an estimated $68K sold.

PharVision Advisers first reported a position in RMNI in Q3 2025 and held it in 2 quarters. The position peaked at $226K in Q3 2025. 116 funds tracked by Wall St. Rank hold RMNI as of Q2 2026.

  • PharVision Advisers reported no remaining Rimini Street position as of Q2 2026 after selling out during the quarter.
  • PharVision Advisers sold 20,720 Rimini Street shares in Q2 2026, an estimated $68K.
  • PharVision Advisers first reported a position in Rimini Street in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's Rimini Street position peaked at $226K in Q3 2025.
  • 116 funds tracked by Wall St. Rank held Rimini Street as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.